Ionchannels and channelopaties in the heart

Similar documents
Ionchannels and channelopaties in the heart. Viktória Szőts

Gene annotation for heart rhythm. 1. Control of heart rate 2. Action Potential 3. Ion channels and transporters 4. Arrhythmia 5.

Strength and weakness of genetic testing in clinical routine.

Genetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic.

Basics of Structure/Function of Sodium and Potassium Channels Barry London, MD PhD

Genetic testing in Cardiomyopathies

Molecular Physiology of Ion Channels That Control Cardiac Repolarization

Genetic Testing for Cardiac Ion Channelopathies

Prolonged QT Syndromes: Congenital and Acquired

Preventing Sudden Death in Young Athletes. Outline. Scope of the Problem. Causes of SCD in Young Athletes. Sudden death in the young athlete

Rhythm and Blues Drugs and QT Prolongation

Name of Presenter: Marwan Refaat, MD

Differences in cardiac atrial and ventricular ion channels

Curriculum vitae Balázs Ördög

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes

Molecular and genetic basis of sudden cardiac death

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Description. Page: 1 of 31. Genetic Testing for Cardiac Ion Channelopathies. Last Review Status/Date: December 2015

Sudden Unexplained Death in Epilepsy (SUDEP) and Dravet Syndrome

CONGENITAL LONG QT SYNDROME(CLQTS) ASSOCIATED WITH COMPLETE ATRIOVENTRICULAR BLOCK. A CASE REPORT.

Normal heart rhythm requires the finely orchestrated

Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies

Genetic Testing for Cardiac Ion Channelopathies. Description

Is There a Genomic Basis to Acquired Channelopathic disease

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

Long QT. Long QT Syndrome. A Guide for Patients

Protocol. Genetic Testing for Cardiac Ion Channelopathies

Pearls of the ESC/ERS Guidelines 2015 Channelopathies

REVIEW ARTICLES Long QT syndrome and anaesthesia

Local Anesthetics. Xiaoping Du Room E417 MSB Department of Pharmacology Phone (312) ;

Case studies in Channelopathies

Wojciech Szczepański, MD, PhD Department of Pediatrics, Endocrinology, Diabetology with Cardiology Division Medical University of Bialystok

TdP Mechanisms and CiPA

Phenotypic Manifestations of Mutations in Genes Encoding Subunits of Cardiac Potassium Channels

What is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment. Andreas Pflaumer

Corporate Medical Policy

La corrente tardiva del Na come nuovo target di terapia antiischemica: ruolo della ranolazina

Genetic Basis of Ventricular Arrhythmias

The action potential and the underlying ionic currents. Norbert Jost, PhD

Phenotypical Manifestations of Mutations in the Genes Encoding Subunits of the Cardiac Sodium Channel

Review. The Genetics of Cardiac Disease Associated with Sudden Cardiac Death

WINDLAND SMITH RICE SUDDEN DEATH GENOMICS LABORATORY

Cardiac arrhythmias are associated with high morbidity

Mechanism of Action of the Antiarrhythmic Agent AZD7009

In Vitro Assessment to Replace the Clinical TQT Study: The Comprehensive In Vitro ProArrhythmia Assay (CiPA) Initiative

Section: Effective Date: Subsection: Original Policy Date: Subject: Page: Last Review Status/Date: Background

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases

Silvia G Priori MD PhD

Mechanisms of Arrhythmogenesis: Focus on Long QT Syndrome (LQTS)

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

TABLE 1. Mutations in the Cardiac Ryanodine Receptor Gene (RyR2) Associated With CPVT and ARVD2* Amino acid Nucleotide Disease Families Familial? Doma

Patient Resources: Cardiac Channelopathies

The long QT syndrome family of cardiac ion channelopathies: A HuGE review* Stephen M. Modell, MD, MS 1, and Michael H.

Genomics and Cardiac Arrhythmias

Genetic Testing for Cardiac Ion Channelopathies

Bear: Neuroscience: Exploring the Brain 3e

Cardiology Genetics Report Long QT Syndrome (LQTS) Panel

Voltage Gated Ion Channels

Etude de Maladies du Rythme Cardiaque à l'aide de Cellules Souches Pluripotentes Induites

Long QT syndrome a genetic cardiac channelopathy

Παναγιώτης Ιωαννίδης. Διευθυντής Τμήματος Αρρυθμιών & Επεμβατικής Ηλεκτροφυσιολογίας Βιοκλινικής Αθηνών

Jaigurumajaigurumajaiguruma. Autonomic Modulation of Ventricular Repolarization in Long QT syndrome. Dr. Rajkumar Mantravadi MBBS 1994 MRCP (UK) 2002

Sudden cardiac death (SCD) accounts for 20% of mortality. Sudden Cardiac Death Compendium. Genetics of Sudden Cardiac Death

Antiarrhythmic Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2017

Antiarrhythmic Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

J Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University

UvA-DARE (Digital Academic Repository) Cardiac sodium channelopathies Amin, A.S.; Asghari-Roodsari, A.; Tan, H.L. Published in: Plügers Archiv

Inherited Arrhythmia Syndromes

Long Q. Long QT Syndrome. A Guide for

Ion channel dysfunction and diseases of the heart

Cardiovascular diseases

COPYRIGHTED MATERIAL. The role of spatial dispersion of repolarization and intramural reentry in inherited and acquired sudden cardiac death syndromes

Hereditary Conditions Predisposing to Sudden Death

Pharmacology of cardiac potassium channels

Pharmacogenomics of Drug-Induced Conditions

Modeling of Anatomy, Electrophysiology and Tension Development in the Human Heart

The Genetic Basis for Cardiac Dysrhythmias and the Long QT Syndrome

The Self-Assessment Approach

The Genetics and Prevention of Sudden Cardiac Death

J. Peter van Tintelen MD PhD Clinical Geneticist Amsterdam, the Netherlands

Deposited on: 29 October 2009

1 Ions, Channels, and Currents

Genetics of cardiomyopathy and channelopathy

About OMICS Group Conferences

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives

2/7/16. Neurons maintain a negative membrane potential. Membrane potential. Ion conductances determine the membrane potential

Role of potassium currents in cardiac arrhythmias

Review Article Genetics of Inherited Arrhythmias in Children

ICD in a young patient with syncope

Cellular Neurobiology BIPN140. 1st Midterm Exam October 18 th, Tuesday Material covered: Lectures 1-6 & Reading

Atrial fibrillation in Cardiac Channelopathies

Channelopathies. Review article Korean J Pediatr 2014;57(1):1-18. Introduction

1. (1 pt) At the equilibrium potential of an ion, what two things are equal? Electrical potential (voltage) and chemical potential (concentration)

Asaad Khoury 2,3 MD, Monther Boulos 1,3 MD, Mahmoud Suleiman 1,3 MD, Miry Blich 1,3 MD, Michael Eldar 4 MD, Ibrahim Marai 1,3 MD,

Transport through biological membranes. Christine Carrington Biochemistry Unit Apr 2010

Sudden cardiac death in Andersen Tawil syndrome

Defining new insight into fatal human arrhythmia: a mathematical analysis

Potassium Channelopathies: Consequences and Impact on Treatment December 4, 2010

Introduction. Circulation

CARDIAC POTASSIUM CHANNEL SUBTYPES: NEW ROLES IN REPOLARIZATION AND ARRHYTHMIA

Transcription:

Ionchannels and channelopaties in the heart Csatorna müködés Több betegség Drugok kapcsolodása csat.hoz Sejtekbe ioncsat.expresszios módszerek, bemutatása Viktória Szőts

Action of membrane transport protein ATP-powered pump Ion chanels Transporters 10 1-10 3 ions/s 10 7-10 8 ions/s 10 2-10 4 ions/s

Nerbonne et al. Circ Res. 2001;89:944-956

Membrane topology of the Kv and Kir2.x K-ionchannels Voltage gated K + channel Inward rectifier K + channel Kv channel CO 2 CO 2 CO 2 H5 H5

Kv complex MiRP N N α C C KChAP β PSD

Különbözı Ioncsatorna alegységek összeszerelıdése Abott et al Neuropharm. 2004

Voltage-Gated Calcium Channels Voltage-gated calcium channels are heteromultimers composed of an α1 subunit and three auxiliary subunits, 2-δ, β and γ. The α1 subunit forms the ion pore and possesses gating functions and, in some cases, drug binding sites. Ten α1 subunits have been identified, which, in turn, are associated with the activities of the six classes of calcium channels. L-type channels have α1c (cardiac), α1d (neuronal/endocrine), α1s (skeletal muscle), and α1f (retinal) subunits; The α1 subunits each have four homologous domains (I-IV) that are composed of six transmembrane helices. The fourth transmembrane helix of each domain contains the voltage-sensing function. The four α1domains cluster in the membrane to form the ion pore. The β-subunit is localized intracellularly and is involved in the membrane trafficking of α1subunits. The γ-subunit is a glycoprotein having four transmembrane segments. The α2 subunit is a highly glycosylated extracellular protein that is attached to the membrane-spanning d-subunit by means of disulfide bonds. The α2-domain provides structural support required for channel stimulation, while the δ domain modulates the voltage-dependent activation and steady-state inactivation of the channel.

Molecular assembly of ion channels Cavα Kvα Kir

Activation and Inactivation Of The Sodium Channel Sodium channels are characterized by voltagedependent activation, rapid inactivation, and selective ion conductance. Depolarization of the cell membrane opens the ion pore allowing sodium to passively enter the cell down its concentration gradient. The increase in sodium conductance further depolarizes the membrane to near the sodium equilibrium potential. Inactivation of the sodium channel occurs within milliseconds, initiating a brief refractory period during which the membrane is not excitable. The mechanism of inactivation has been modeled as a "hinged lid" or "ball and chain", where the intracellular loop connecting domains III and IV of the a subunit closes the pore and prevents passage of sodium ions.

Ionic currents and ion transporters responsible for cardiac action potential Abriel H. et al., Swiss Med Wkly 2004, 685-694. www.sm w. ch

Proposed cellular mechanism for the development of Torsade de pointes in the long QT syndrome

Risk factors for developing Torsade de pointes Genetic variants (polymorphysm or mutations) Abriel H. et al., Swiss Med Wkly 2004, 685-694.

Ionic current, proteins and genes associated with inherited arrhythmias Napolitano et al. Pharm. & ther. 2006,110:1-13

Congenital and aquired forms of long QT syndromes Abriel H. et al., Swiss Med Wkly 2004, 685-694. www.sm w. ch

K+, Na+ channel LQT-associated genes and proteins Current Genes Disease I To1 I Ks I Kr I Na I k1 I kur I kach I katp I CaL Kv4.3 KvLQT1(KCNQ1) Mink (KCNE1) HERG (KCNH2) MiRP1 (KCNE2) SCN5A Kir2.1 (KCNJ2) Kv1.7(KCNA7),Kv1.5 Kir3.4 Kir6.2 Cav1.2 (CACNA1c) LQT LQT1, JLN1 LQT5, JLN2 LQT2 LQT6, FAF LQT3 Brugada Syndrome, Cardiac conduction defect, Sick sinus syndrome LQT7 Andersen-Tawil Syndrome Progressziv familial heart Block1 LQT8 Timothy Syndrome

Prolonged QT interval on ECG (reflects prolonged APD) APD governed by a delicate balance between inward (Na + or Ca + ) and outward (K + ) ionic current Affecting the Na + or Ca + channel prolong APD via gain-offfunction mechanism, while mutation in genes encoding K + channel by loss-off-function mechanism

Gene mutations in LQT1 and LQT2 HERG KCNH2 KvLQT1 KCNQ1 LQT2 LQT1

Molecular structure and the membrane topology of the HERG channel Mutations in HERG channel

Pivotal role of Ser phosphorilation as a regulatory mechanism in Cav1.2 mode1/mode2 gating. Timothy s syndrome

Current Genes Disease I Kr I K1 I Ks HERG (KCNH2) Kir2.x (KCNJ2) KvLQT1(KCNQ1) ShortQT I Ca CASQ2 CPVT catecholamine-induced (Calsequestrin2) polymorphic CPVT ventricular tachycardia RyR2 CPVT β 1 -adrenoceptor (β 1 -AR) β 2 -adrenoceptor (β 2 -AR) Kv3.1, Kv3.3 Risk factor, modify disease or influence progression of disease Risk factor, modify disease or influence progression of disease AF

Complexity of protein-protein interaction in cardiomyocytes

Missense mutation in calsequestrin2 (CASQ2) wild type Syncope Seizures or Sudden death In response to Physical activity or Emotional stress mutant Associated with autosomal recessive catecholamineinduced polymorphic ventricular tachycardia (CPVT)

Kir2.1 ionchannel has an autosomal dominant mutation in Andersen-Tawil Syndrome Cardiac arrhytmias Periodic paralysis Dysmorphic bone structure(scoliosis, low-set ears, small chin, broad forehead

Facial and sceletal features in Andersen- Tawil syndrome

GIRK mutation

ANP role

Gene-specific mutation study Genexpression study Microarray, qrt-pcr Proteomica

Kir2.x analysis by RT-PCR kir2.x mrna in dog & human 0.01400000 0.01200000 0.01000000 0.00800000 0.00600000 0.00400000 0.00200000 0.00000000-0.00200000 Kir2.1 Kir2.2 Kir2.3 Kir2.4 HUMAN DOG

Expression of Kv1.5 protein in human and dog kda 75 66 RV LV RA LA RV LV DOG HUMAN 6 RA LA Relative amount of Kv1.5 5 4 3 2 1 0 HUMAN DOG n=12 n= 6 LV LA

Co-localization of Kvβ β2 auxillary subunit with Kv1.5 in dog left ventricular myocytes Kv1.5-FITC Kvβ β2-texas red 100 µ Kv1.5-FITC Kvβ β2-texas red